Martijn van de Bunt
Zealand Pharma (Denmark)(DK)
Publications by Year
Research Areas
Pancreatic function and diabetes, Genetic Associations and Epidemiology, Metabolism, Diabetes, and Cancer, Bioinformatics and Genomic Networks, Epigenetics and DNA Methylation
Most-Cited Works
- → The genetic architecture of type 2 diabetes(2016)1,100 cited
- → Colocalization of GWAS and eQTL Signals Detects Target Genes(2016)762 cited
- → Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance(2016)601 cited
- → Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants(2014)545 cited
- → Improved Detection of Common Variants Associated with Schizophrenia by Leveraging Pleiotropy with Cardiovascular-Disease Risk Factors(2013)529 cited
- → Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation(2018)484 cited
- → Human β Cell Transcriptome Analysis Uncovers lncRNAs That Are Tissue-Specific, Dynamically Regulated, and Abnormally Expressed in Type 2 Diabetes(2012)461 cited
- → Identification of type 2 diabetes loci in 433,540 East Asian individuals(2020)449 cited
- → Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci(2015)421 cited
- → Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells(2019)314 cited